These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7876575)

  • 1. ELISA for titration of antibodies to tetanus toxoid in sera of immunized guinea pigs as an alternative to the toxin neutralization test in mice.
    Gupta RK
    J Immunol Methods; 1995 Feb; 179(2):277-9. PubMed ID: 7876575
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an ELISA for measuring the activity of tetanus toxoid in vaccines and comparison with the toxin neutralization test in mice.
    Manghi MA; Pasetti MF; Brero ML; Deluchi S; di Paola G; Mathet V; Eriksson PV
    J Immunol Methods; 1994 Jan; 168(1):17-24. PubMed ID: 8288891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay.
    Gupta RK; Siber GR
    Biologicals; 1994 Sep; 22(3):215-9. PubMed ID: 7811454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use.
    Pharmeuropa Spec Issue Biol; 2002 Oct; 2001(2):1-92. PubMed ID: 11820120
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    Biologicals; 1991 Jan; 19(1):23-9. PubMed ID: 2049173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against tetanus toxin and toxoid.
    Ahnert-Hilger G; Bizzini B; Goretzki K; Müller H; Völckers C; Habermann E
    Med Microbiol Immunol; 1983; 172(2):123-35. PubMed ID: 6193402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea.
    Barile MF; Hardegree MC; Pittman M
    Bull World Health Organ; 1970; 43(3):453-9. PubMed ID: 5312999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the immune response to papain digestion products of tetanus toxin.
    Helting TB; Nau HH
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):59-63. PubMed ID: 6711309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
    Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
    Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation.
    Sesardic D; Winsnes R; Rigsby P; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):69-76. PubMed ID: 14960263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are potency tests for tetanus vaccines really necessary?
    Knight PA
    Dev Biol Stand; 1986; 64():39-45. PubMed ID: 3792656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ELISA system for tetanus toxoid potency tests: An alternative to lethal challenge.
    Iwaki M; Kenri T; Senoh M
    Biologicals; 2023 May; 82():101681. PubMed ID: 37130447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy demonstration of tetanus vaccines by double antigen ELISA.
    Rosskopf U; Noeske K; Werner E
    Pharmeuropa Bio; 2005 Sep; 2005(1):31-52. PubMed ID: 16336937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendriksen CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
    Biologicals; 1994 Sep; 22(3):257-68. PubMed ID: 7811460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative estimation of diphtheria and tetanus toxoids. 3. Comparative assays in mice and in guinea-pigs of two tetanus toxoid preparations.
    Lyng J; Heron I; Ljungqvist L
    Biologicals; 1990 Jan; 18(1):3-9. PubMed ID: 2317352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative approach and evaluation of three potency assay methods for testing adsorbed tetanus toxoid.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):12-8. PubMed ID: 9842159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for serological potency testing of tetanus vaccines for human use: Clostridium tetani guinea pig antiserum (human).
    Hendriksen C; van der Gun J; Winsnes R; Urdal T; Rautmann G; Esposito-Farese ME
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):7-11. PubMed ID: 11705101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.